logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
R

Ravindran Kanesvaran

National Cancer Centre Singapore

44H-index
425Paper Count
8.5KCitation Count
Published Papers 145
Publication Date
logo
Real-world incidence of G3-G4 adverse events with enfortumab vedotin in patients with advanced urothelial carcinoma (ARON-2EV study)
errScientific Reports
IF3.9
err2026-07-29
err0
errOAAI
errPatrizia Giannatempo; Shilpa Gupta; Mimma Rizzo; Karl Mayrhofer; Renate Pichler; Dora Niedersuess-Beke; Ondrej Fiala; Javier Molina-Cerrillo; Marc R. Matrana; Randi Kinhel; Luca Galli; Alessia Salfi; Tomas Buchler; Alina Pirshtuk; Jawaher Ansari; Anca Zgura; Ray Manneh Kopp; Giandomenico Roviello; Jindrich Kopecky; Kirstin Binz; Akihiro Yano; Martin Angel; Se Hoon Park; Ravindran Kanesvaran; Zin W. Myint; Yüksel Ürün; Francesco Massari; Fernando Sabino Marques Monteiro; Kannan Sridharan; Matteo Santoni
errShare
errSave
LESION LOCATION IMPACT ON EARLY CANCER OUTCOMES AND SEXUAL FUNCTIONAL RECOVERY AFTER FOCAL CRYOTHERAPY FOR PROSTATE CANCER
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errYang, XinYan; Ho, Hua Thun; Tan, Yu Guang; Lam, Shelby Xuan Lin; Goh, Bee Leng; Peng, Jiping; Chen, Kenneth; Yuen, John Shyi Peng; Cheng, Christopher Wai Sam; Ho, Henry Sun Sien; Tuan, Jeffrey; Chua, Melvin Lee Kiang; Kanesvaran, Ravindran; Hong, Boon Hao; Tan, Kah Min; Khor, Li Yan; Lim, Tony Kiat Hon; Ong, Enya Hui Wen; Gupta, Rajan T.; Cheng, Lionel Tim-Ee; Polascik, Thomas J.; Ngo, Nye Thane; Law, Yan Mee; Tay, Kae Jack
errShare
errSave
Empowering Patients: The Role of Shared Treatment Decision-Making in Advanced Bladder Cancer—A Podcast
errAdvances in Therapy
IF4
err2026-04-15
err0
errOAAI
errRavindran Kanesvaran; Patrizia Giannatempo; Alex Filicevas
errShare
errSave
Outcomes of a prospective cohort study of PREoperative therapy and supportive care in early & locally advanced breast cancers—PreSCella study
errnpj Breast Cancer
IF7.6
err2026-01-28
err0
errOAAI
errHan Yi Lee; Whee Sze Ong; Jasmine Yun Ting Tan; Jun Ma; Zewen Zhang; Si Ying Tan; Grace Meijuan Yang; Irene Teo; Wei Lin Goh; Mabel May Leng Tan; Yoon Sim Yap; Jack Junjie Chan; Ryan Shea Ying Cong Tan; Wu Meng Tan; Elaine Lim; Huren Sivaraj; Sok Yuen Beh; Lay Tin Soh; Wen Yee Chay; Rebecca Dent; Ravindran Kanesvaran; Mabel Wong; Benita Kiat Tee Tan; Fuh Yong Wong; Kiak Mien Veronique Tan; Tira J. Tan
errShare
errSave
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma
errInternational Journal of Clinical Oncology
IF2.8
err2026-01-21
err0
errOAAI
errEiji Kikuchi; Michiel S. Van der Heijden; Begoña P. Valderrama; Shilpa Gupta; Jens Bedke; Sang Joon Shin; Jian-Ri Li; Jun Guo; Pongwut Danchaivijitr; Ravindran Kanesvaran; Se Hoon Park; Wen-Pin Su; Shuya Kandori; Woo Kyun Bae; Alvin Wong; Seema Gorla; Abhishek Bavle; Xuesong Yu; Yi-Tsung Lu; Thomas Powles
errShare
errSave
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
errClinical Genitourinary Cancer
IF2.7
err2026-01-01
err0
PREAI
errLemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
SCREENing smarter: outperforming IMDC in predicting first-year mortality among patients undergoing cytoreductive nephrectomy
errWorld Journal of Urology
IF2.9
err2025-11-22
err0
PREAI
errLingyue Yu; Alvin Yuanming Lee; Khi Yung Fong; Ee Jean Lim; Yu Guang Tan; Kae Jack Tay; Wei Chong Tan; Johan Chan; Yien Ning Sophia Wong; Henry Sun Sien Ho; John Shyi Peng Yuen; Ravindran Kanesvaran; Kenneth Chen
errShare
errSave
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study
errClinical & Experimental Metastasis
IF3.2
err2025-11-21
err0
PREAI
errRenate Pichler; Gerald Klinglmair; Kirstin Binz; Enrique Grande; Alina Pirshtuk; Hideki Takeshita; Yüksel Ürün; Javier Molina-Cerrillo; Zin W. Myint; Alfonso Gómez de Liaño; Augusto Mota; Alessia Salfi; Wataru Fukuokaya; Enrico Sammarco; Martin Angel; Jakub Kucharz; Deniz Tural; Ondřej Fiala; Alejo Rodriguez-Vida; Franco Morelli; Alexandr Poprach; Mobin Safi; Alvaro Pinto; Francesco Massari; Sebastiano Buti; Shilpa Gupta; Fernando Sabino Marques Monteiro; Andrey Soares; Nicola Battelli; Ravindran Kanesvaran; Matteo Santoni
errShare
errSave
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
errnpj Precision Oncology
IF8
err2025-11-13
err0
errOAAI
errJing Yi Lee; Aya El Helali; Donavan Jia Jie Tan; Zi Yi Wan; Donald Poon; Jens Samol; Tsz Him So; Su Pin Choo; Ravindran Kanesvaran; Cheng-Vai Hui; Joseph Siu-Kie Au; Timothy Yip; Ross A. Soo; Michelle Pek; Ruifen Weng; Bin Tean Teh; Min-Han Tan; Jonathan Poh; Jason Yongsheng Chan
errShare
errSave
Primary MRI versus PSA-gated scans in Prostate Cancer Screening – how ready is it for mainstream implementation?
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-11-06
err0
PREAI
errJun Heng Lim; Christopher Yong-Zyn Lo; Rehena Sultana; Jeremy Yong Jie Tay; Raj Vikesh Tiwari; Thomas Kong Ngai Chan; Melvin Chua Lee Kiang; Ravindran Kanesvaran; Shawn Kok Shi Xian; Min On Tan; Lui Shiong Lee
errShare
errSave
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort
errEuropean Urology Open Science
IF4.5
err2025-11-03
err0
errOAAI
errOndrej Fiala; Francesco Grillone; Kazutoshi Fujita; Enrique Grande; Patrizia Giannatempo; Tarek Taha; Zin W. Myint; Thomas Büttner; Alfonso Gómez de Liaño; Ravindran Kanesvaran; Gaetano Facchini; Akihiro Yano; Luigi Formisano; Alexandr Poprach; Vincenza Conteduca; Alina Pirshtuk; Hana Studentova; Jindrich Kopecky; Enrico Sammarco; Augusto Mota; Lorena Incorvaia; Cecilia Nasso; Michele Maffezzoli; Aruni Ghose; Andrey Soares; Sebastiano Buti; Fernando Sabino Marques Monteiro; Francesco Massari; Shilpa Gupta; Joaquim Bellmunt; Giuseppe Luigi Banna; Matteo Santoni
errShare
errSave
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errGrande, Enrique; Bellmunt, Joaquim; Hussain, Syed A.; Al Mansour, Mubarak M.; Bamias, Aristotle; Barthelemy, Philippe; Benjamin, David J.; Blais, Normand; Bourlon, Maria T.; Castellano, Daniel; Danchaivijitr, Pongwut; Fernandez Lazzaro, Mauricio; Giannatempo, Patrizia; Guerrero-Ramos, Felix; Iacovelli, Roberto; Ivanyi, Philipp; Jung, Eun Hee; Kanesvaran, Ravindran; Manneh, Ray; Marinho, Joana C.; Matsubara, Nobuaki; Merseburger, Axel S.; Mukherji, Deborah; Park, Chandler H.; Tran, Ben; da Trindade, Karine Martins; Urun, Yuksel; Kamat, Ashish M.; Birtle, Alison J.
errShare
errSave
Final results of the phase 3 COSMIC-313 study comparing first-line cabozantinib plus nivolumab and ipilimumab with nivolumab plus ipilimumab in patients with advanced renal-cell carcinoma
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errAlbiges, Laurence; Motzer, Robert; Aguirre, Sergio Arnoldo Trevino; Kanesvaran, Ravindran; Centkowski, Piotr; Reimers, Melissa A.; Sade, Juan Pablo; Pouessel, Damien; Biscaldi, Elisa; Esteban, Emilio; Angel, Jose; Arija, Arranz; Tykodi, Scott; Ma, Haijun; Zhou, Lei; Losio, Maximiliano van Kooten; Simmons, Andrew; Braun, David; Choueri, Toni; Powles, Thomas
errShare
errSave
EORTC QLU-C10D was similarly valid and sensitive as EQ-5D-5L but more responsive to cancer patients’ health deterioration
errJournal of Clinical Epidemiology
IF5.2
err2025-08-30
err0
errOAAI
errLuying Wang; Mihir Gandhi; Ravindran Kanesvaran; Mohamad Farid Bin Harunal Rashid; Dawn Qingqing Chong; Wen-Yee Chay; Richard Norman; Madeleine T. King; Nan Luo
errShare
errSave
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma
errFuture Oncology
IF2.6
err2025-07-29
err0
errOAAI
errThomas B. Powles; Enrique Grande; Nimira Alimohamed; Niara Oliveira; Srikala S. Sridhar; Alexandra Drakaki; Ravindran Kanesvaran; Yohann Loriot; Andrea Necchi; Sonia Franco; Dingfeng Jiang; Kristel Apolinario; Wei Zhang; Matthew D. Galsky
errShare
errSave
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non–clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study
errEuropean Urology Focus
IF5.6
err2025-07-29
err0
PREAI
errFrancesco Massari; Veronica Mollica; Ray Manneh Kopp; Enrique Grande; Ondřej Fiala; Ravindran Kanesvaran; Haoran Li; Timothy J. Schieber; Maria José Juan Fita; Alexandr Poprach; Cristian Lolli; Maria T. Bourlon; Alfonso Gómez de Liaño; Francesco Grillone; Kaisa Sunela; Alessandro Rizzo; Marwan Ghosn; Linda Cerbone; Tarek Taha; Yüksel Ürün; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Edoardo Lenci; Inmaculada Orejana Martin; Hussam Abu-Sini; Pasquale Rescigno; Dipen Bhuva; Andre Poisl Fay; Vincenza Conteduca; Ahmet Yildirim; Matteo Rosellini; Umut Akova; Elisa Tassinari; Hatice Bölek; Andrey Soares; Fernando Sabino Marques Monteiro; Sebastiano Buti; Mehmet Asim Bilen; Matteo Santoni
errShare
errSave
Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data
errJournal of the National Cancer Center
IF9.4
err2025-05-29
err0
errOAAI
errKae Jack Tay; Boon Hao Hong; Enya Hui Wen Ong; Kah Min Tan; Gianella Cabuhat Pacho; Samantha Jingxuan Wong; Yu Guang Tan; Yan Mee Law; Nye Thane Ngo; Puay Hoon Tan; John S.P. Yuen; Henry S.S. Ho; Kenneth Chen; Jiping Peng; Clare Wei Tian Foo; Xin Xiu Sam; Jeffrey K.L. Tuan; Ravindran Kanesvaran; Rajan T. Gupta; Steven Rozen; Thomas J. Polascik; Yang Liu; James Proudfoot; Elai Davicioni; Li Yan Khor; Melvin Lee Kiang Chua
errShare
errSave
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study
errCANCER IMMUNOLOGY IMMUNOTHERAPY
IF5.1
err2025-05-09
err0
errOAAI
errPorta, Camillo; Massari, Francesco; Taha, Tarek; Grande, Enrique; Bourlon, Maria T.; Kanesvaran, Ravindran; Basso, Umberto; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Myint, Zin W.; Fornarini, Giuseppe; Buttner, Thomas; Park, Se Hoon; Urun, Yueksel; De Giorgi, Ugo; Pichler, Renate; Rescigno, Pasquale; Buchler, Tomas; Studentova, Hana; Melichar, Bohuslav; Ansari, Jawaher; Mollica, Veronica; Kucharz, Jakub; Rizzo, Mimma; Rizzo, Alessandro; Kopp, Ray Manneh; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Bamias, Aristotelis; Santoni, Matteo
errShare
errSave
Quality-of-care indicators for oncology management: an analysis of Asia-Pacific healthcare and oncology indicators
errESMO OPEN
IF8.3
err2025-03-01
err0
errOAAI
errKanesvaran, R.; Wong, E. Y. T.; Keam, B.; Prasongsook, N.; Malhotra, H.; Blay, J. -y.
errShare
errSave
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physicians
errCANCER TREATMENT REVIEWS
IF10.5
err2025-03-01
err0
errOAAI
errGrande, Enrique; Hussain, Syed A.; Barthelemy, Philippe; Kanesvaran, Ravindran; Giannatempo, Patrizia; Benjamin, David J.; Hoffman, Jason; Birtle, Alison
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
T
Toni K. Choueiri
H-index: 149 · Papers: 2.4K
C
Charles G. Drake
H-index: 133 · Papers: 1.2K
View more